TNXP | Woo Trader

CTNXP - Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102, for the management of fibromyalgia syndrome and TNX-105 to treat symptoms of post-traumatic stress disorder. Tonix Pharmaceuticals Holding Corp. is headquartered in New York.

Last Close	$0.64^-1.54%	Range	$0.63-$0.69
Volume	149,200^-81%	Market Cap	$5.01 M
Avg Daily $	$506,483	Avg Volume	791,380
52 Week High	$5.11^-87%	52 Week Low	$0.60^+7%
Insider Score	Low Buying	%Insiders	4.12%
%Institutions	13.71%	%M.F.	2.97%
Price Target	$8.00^+1,150%	Mean Rating	Perform
Zacks Target	$2.15^+236%	Zacks Rating	Buy
TR Target	$1.25^+95%	TR Rating	Hold
News/Blogs	N/A	With Impact	N/A
Next Earnings	2018-11-06	Forward EPS	‑$0.65
EPS	-2.86	P/E	-0.22
Dividend	N/A	Yield	N/A

Wootrader.com is moving to https://financeboards.com - sign up for a free account.

CTNXP - Tonix Pharmaceuticals Holding Corp.

This full content is available for membership level Budding Investor or higher. You can register for a new account now.